Skip to main content
. 2004 May;1(2):37–41.

Cost of recently approved biotech therapies

Drug Used to treat Annual cost
Omalizumab (Xolair) Allergic asthma $15,0001
Enfuvirtide (Fuzeon) Advanced HIV $20,0001
Cetuximab (Erbitux) Colon cancer $120,0002
Laronidase (Aldurazyme) MPS-1, genetic enzyme deficiency $170,0001

MPS=MUCOPOLYSACCHARIDOSIS

1

CAREMARK RX TRENDS REPORT 2003

2

MEDCO HEALTH SOLUTIONS VIA BALTIMORE SUN